Efficacy and safety of Kanglaite injection combined with first-line platinum-based chemotherapy in patients with advanced NSCLC: a systematic review and meta-analysis of 32 RCTs | Zendy

Juan Li | Zendy; Wanqing Li | Zendy; Guanghui Zhu | Zendy; Ruike Gao | Zendy; Ying Zhang | Zendy; Wei Hou | Zendy; Jie Li | Zendy

Open Access

Efficacy and safety of Kanglaite injection combined with first-line platinum-based chemotherapy in patients with advanced NSCLC: a systematic review and meta-analysis of 32 RCTs

Author(s) -

Juan Li,

Wanqing Li,

Guanghui Zhu,

Ruike Gao,

Ying Zhang,

Wei Hou,

Jie Li

Publication year - 2020

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 19

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-20-616

Subject(s) - medicine , nausea , leukopenia , chemotherapy , adverse effect , vomiting , relative risk , meta analysis , randomized controlled trial , oncology , cisplatin , confidence interval , subgroup analysis

As a Chinese medicine injections, Kanglaite injection (KLT) is a complementary or alternative therapy for first-line platinum-based chemotherapy. However, the effect that certain factors, including the dose of KLT, chemotherapy cycles, evaluation criteria, or supportive treatment, have on the efficacy of the objective response rate (ORR), median survival time (MST), and adverse reactions is still unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research